September 04, 2020
11 min watch
Save
VIDEO: Hovanesian interviews Mazzo on ophthalmology's future in coronavirus era, part 4
OSN Cataract Surgery Section Editor John A. Hovanesian, MD, FACS, and ophthalmic industry veteran Jim Mazzo discuss the changes taking place in the ophthalmic industry and physician practices in the coronavirus pandemic era.
In this installment, they discuss the recent surge in elective surgeries and whether that will be a long-term trend or a short-term burst from the lockdown, as well as challenges in re-staffing ophthalmic practices and how to become more efficient practitioners.
Published by:
Sources/Disclosures
Collapse
Source:
John A. Hovanesian, MD, FACS, and Jim Mazzo
Disclosures:
Hovanesian reports a financial interest in 1-800-DOCTORS, Acufocus, Aerie, Alcon, Allegro, Allergan, BlephEx, Cord, Eyedetec, Glaukos, Guardion, Johnson & Johnson Vision, Katena, Ivantis, Kala, MDbackline, Novartis, Ocular Therapeutix, Omeros, Sarentis Ophthalmics, Sensimed, Tear Film Innovations and Valeant.
Mazzo reports a financial interest in Avellino Labs, Carl Zeiss Meditec, Centricity, IanTech, LensGen, Neurotech, ReFocus and Visus.
Read more about